Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles
Raimond Heukers(Utrecht University), Paul M.P. van Bergen en Henegouwen(Utrecht University), Richard A. Pepermans(Utrecht University), Wim E. Hennink(Utrecht University), Raymond M. Schiffelers(University Medical Center Utrecht), Rob C. Roovers(Utrecht University), Smiriti Raghoenath(Utrecht University), Erica De Zan(Nuffield Orthopaedic Centre), Rob Haselberg(Utrecht University), Işıl Altıntaş(Genmab (Netherlands)), Robbert J. Kok(Utrecht University)
Cited by 87
Related Papers
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
State‐of‐the‐Art Design and Rapid‐Mixing Production Techniques of Lipid Nanoparticles for Nucleic Acid Delivery
|Small Methods|2018|324
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285